Gil Arvatz

928 total citations
14 papers, 752 citations indexed

About

Gil Arvatz is a scholar working on Molecular Biology, Cell Biology and Epidemiology. According to data from OpenAlex, Gil Arvatz has authored 14 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cell Biology and 3 papers in Epidemiology. Recurrent topics in Gil Arvatz's work include Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Gil Arvatz is often cited by papers focused on Proteoglycans and glycosaminoglycans research (11 papers), Fibroblast Growth Factor Research (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Gil Arvatz collaborates with scholars based in Israel and United States. Gil Arvatz's co-authors include Israël Vlodavsky, Neta Ilan, Flonia Levy‐Adam, Sari Feld, Inna Naroditsky, Itay Shafat, Victoria Cohen‐Kaplan, Ilana Doweck, Uri Barash and Marina Weissmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Gil Arvatz

14 papers receiving 743 citations

Peers

Gil Arvatz
Comparison fields: 5 of 66
  • Molecular Biology 513
  • Cell Biology 453
  • Epidemiology 112
  • Organic Chemistry 88
  • Physiology 77
Sari Feld Israel
J. Paul Schofield United Kingdom
Paolo G.V. Martini United States
Guo-Yun Chen United States
Sibylla Martinelli Switzerland
Jean‐Jacques Candelier France
Michael Plotnick United States
T. Bunte Germany
Irene Ivhed Sweden
Shinichiro Yoshida Japan
Sari Feld Israel View profile →
Citations per field, relative to Gil Arvatz
Gil Arvatz · 1×
Citations per year, relative to Gil Arvatz
Gil Arvatz · 1×

Countries citing papers authored by Gil Arvatz

Since Specialization
Citations

This map shows the geographic impact of Gil Arvatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Arvatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Arvatz more than expected).

Fields of papers citing papers by Gil Arvatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gil Arvatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Arvatz. The network helps show where Gil Arvatz may publish in the future.

Co-authorship network of co-authors of Gil Arvatz

This figure shows the co-authorship network connecting the top 25 collaborators of Gil Arvatz. A scholar is included among the top collaborators of Gil Arvatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gil Arvatz. Gil Arvatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
# Title Journal Authors Indexed citations
1 Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2 Frontiers in Oncology Sari Feld, Gil Arvatz et al. 8
2 Exosome secretion affects social motility in Trypanosoma brucei PLoS Pathogens Dror Eliaz, Gil Arvatz et al. 77
3 Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth Cancer Research Sari Feld, Ilana Doweck et al. 35
4 Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis Proceedings of the National Academy of Sciences Marina Weissmann, Gil Arvatz et al. 89
5 Heparanase and cancer progression: New directions, new promises Human Vaccines & Immunotherapeutics Gil Arvatz, Marina Weissmann et al. 27
6 Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease Molecular Genetics and Metabolism Tali Kizhner, Yaniv Azulay et al. 94
7 Clinical Significance of Heparanase Splice Variant (T5) in Renal Cell Carcinoma: Evaluation by a Novel T5-Specific Monoclonal Antibody PLoS ONE Uri Barash, Gil Arvatz et al. 10
8 Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression Arteriosclerosis Thrombosis and Vascular Biology Miry Blich, Amnon Golan et al. 115
9 The heparanase system and tumor metastasis: is heparanase the seed and soil? Cancer and Metastasis Reviews Gil Arvatz, Itay Shafat et al. 85
10 Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity Journal of Biological Chemistry Flonia Levy‐Adam, Sari Feld et al. 113
11 Post-transcriptional regulation of heparanase gene expression by a 3′ AU-rich element The FASEB Journal Gil Arvatz, Uri Barash et al. 33
12 Post‐transcriptional regulation of heparanase gene expression by a 3’ AU‐rich element The FASEB Journal Gil Arvatz, Uri Barash et al. 4
13 A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics The FASEB Journal Uri Barash, Victoria Cohen‐Kaplan et al. 36
14 RNAi interference of XPO1 and Sm genes and their effect on the spliced leader RNA in Trypanosoma brucei Molecular and Biochemical Parasitology Moshe Biton, Michal Mandelboim et al. 26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026